8QW4 image
Deposition Date 2023-10-18
Release Date 2024-09-04
Last Version Date 2024-10-23
Entry Detail
PDB ID:
8QW4
Keywords:
Title:
FZD3 in complex with nanobody 9
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Lama glama (Taxon ID: 9844)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
Aggregation State:
CELL
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Frizzled-3
Gene (Uniprot):FZD3
Chain IDs:A
Chain Length:525
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Nanobody Nb9
Chain IDs:B
Chain Length:125
Number of Molecules:1
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Structural insights into Frizzled3 through nanobody modulators.
Nat Commun 15 7228 7228 (2024)
PMID: 39174501 DOI: 10.1038/s41467-024-51451-1

Abstact

The Wnt receptor Frizzled3 (FZD3) is important for brain axonal development and cancer progression. We report structures of FZD3 in complex with extracellular and intracellular binding nanobodies (Nb). The crystal structure of Nb8 in complex with the FZD3 cysteine-rich domain (CRD) reveals that the nanobody binds at the base of the lipid-binding groove and can compete with Wnt5a. Nb8 fused with the Dickkopf-1 C-terminal domain behaves as a FZD3-specific Wnt surrogate, activating β-catenin signalling. The cryo-EM structure of FZD3 in complex with Nb9 reveals partially resolved density for the CRD, which exhibits positional flexibility, and a transmembrane conformation that resembles active GPCRs. Nb9 binds to the cytoplasmic region of FZD3 at the putative Dishevelled (DVL) or G protein-binding site, competes with DVL binding, and inhibits GαS coupling. In combination, our FZD3 structures with nanobody modulators map extracellular and intracellular interaction surfaces of functional, and potentially therapeutic, relevance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures